Press Releases

Women with Stage III ovarian cancer when treated with a combination of intravenous (IV) and intra-abdominal chemotherapy, following the successful surgical removal of tumors, survived almost a year longer than those who received IV chemotherapy alone.

A study that shows lung cancer risk varies widely among smokers may help individuals and their doctors decide if voluntary screening is appropriate for them.

In a development that holds promise for advancing the treatment of patients with sarcoma, researchers at Memorial Sloan Kettering Cancer Center have developed a new prognostic tool that is more accurate than any previously available for this disease.